Given that changes in GVHD are commonly attributed to differences in Treg number or function, underscored by the fact that exogenous Treg administration can prevent GVHD (41–44), we sought to understand the impact of AMPK deficiency on Tregs in the posttransplant environment. Here, PRKAA2 is linked to graft versus host disease.